Literature DB >> 2533066

Ontogeny and tissue distribution of leukocyte-common antigen bearing cells during early development of Xenopus laevis.

H Ohinata1, S Tochinai, C Katagiri.   

Abstract

To analyze the ontogenic emergence of leukocytes during early development, a mouse monoclonal antibody (IgG1), designated as XL-1, was produced against the peritoneal macrophages of adult Xenopus laevis. The XL-1 determinant was expressed on all types of leukocytes, including lymphocytes, granulocytes, thrombocytes and macrophages, but not on erythrocytes of either larvae or adults. Immunohistochemical observations of the hemopoietic organs revealed that the XL-1+ cells with granulocyte and/or macrophage morphology appeared at st.36-37 in the liver, at st.44-45 in the mesonephric and the thymus rudiments, and at st.47 in the spleen. The XL-1 determinant was expressed on the precursor cells of T lymphocytes in the thymus rudiments at st.46-47, on the pre-B cells in the liver rudiments at st.47, and on lymphocytes in the spleen at st.48-49. A few XL-1+ cells were present in the ventral blood island of the st.35/36 embryos, where differentiating erythrocytes had predominated since st.28. XL-1+ cells with a macrophage-like morphology were found in several locations of the mesenchyme in the st.32 embryos, before the establishment of vascularization at st.33/34 and far earlier than the emergence of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2533066     DOI: 10.1242/dev.107.3.445

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  2 in total

Review 1.  Comparative and developmental study of the immune system in Xenopus.

Authors:  Jacques Robert; Yuko Ohta
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

2.  spib is required for primitive myeloid development in Xenopus.

Authors:  Ricardo M B Costa; Ximena Soto; Yaoyao Chen; Aaron M Zorn; Enrique Amaya
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.